Retracted: Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (<scp>GERD</scp>) in China
- DOI
- 10.1111/apt.13334
- Published
- 2015-07-31
- Container
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/apt.13334,
title = {Retracted: Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (<scp>GERD</scp>) in China},
author = {J. Sun and C. Yang and H. Zhao and P. Zheng and J. Wilkinson and B. Ng and Y. Yuan},
year = {2015},
journal = {Alimentary Pharmacology \& Therapeutics},
doi = {10.1111/apt.13334},
url = {https://doi.org/10.1111/apt.13334}
}RIS
TY - JOUR TI - Retracted: Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (<scp>GERD</scp>) in China AU - J. Sun AU - C. Yang AU - H. Zhao AU - P. Zheng AU - J. Wilkinson AU - B. Ng AU - Y. Yuan PY - 2015 JO - Alimentary Pharmacology & Therapeutics DO - 10.1111/apt.13334 UR - https://doi.org/10.1111/apt.13334 ER -
APA
Sun, J., Yang, C., Zhao, H., Zheng, P., Wilkinson, J., Ng, B., & Yuan, Y. (2015). Retracted: Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (<scp>GERD</scp>) in China. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.13334
Source records
- crossref · retrieved 2026-09-24T22:27:13.889Z